Changes in Bone Metabolism in Morbidly Obese Patients After Bariatric Surgery: A Meta-Analysis

Obesity Surgery

Volumn 26, Issue 1, 2016, Pages 91-97

  Liu, Cong ^a   Wu, Dan ^a   Zhang, Jing Fan ^a   Xu, Duo ^a   Xu, Wan Feng ^a   Chen, Yu ^a   Liu, Bing Yang ^a   Li, Ping ^a   Li, Ling ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Bariatric surgery; Bone metabolism; Bone mineral density; Morbid obesity; Osteoporosis

Indexed keywords

25 HYDROXYVITAMIN D; ALKALINE PHOSPHATASE BONE ISOENZYME; AMINO TERMINAL TELOPEPTIDE; CALCIUM; CITRATE CALCIUM; COLECALCIFEROL; PARATHYROID HORMONE; VITAMIN D; 25-HYDROXYVITAMIN D; ALKALINE PHOSPHATASE; COLLAGEN TYPE 1; COLLAGEN TYPE I TRIMERIC CROSS-LINKED PEPTIDE; PEPTIDE;

ARTICLE; BARIATRIC SURGERY; BLOOD SAMPLING; BONE DENSITY; BONE DISEASE; BONE METABOLISM; CALCIUM BLOOD LEVEL; EMBASE; HORMONE DETERMINATION; HUMAN; MEDLINE; META ANALYSIS; MORBID OBESITY; OUTCOME ASSESSMENT; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; SERUM; STOMACH BYPASS; SURGICAL PATIENT; SYSTEMATIC REVIEW; URINALYSIS; VITAMIN BLOOD LEVEL; ANALOGS AND DERIVATIVES; BLOOD; BONE REMODELING; OBESITY, MORBID; URINE;

ALKALINE PHOSPHATASE; BARIATRIC SURGERY; BONE DENSITY; BONE REMODELING; CALCIUM; COLLAGEN TYPE I; HUMANS; OBESITY, MORBID; PARATHYROID HORMONE; PEPTIDES; VITAMIN D;

EID: 84952983666     PISSN: 09608923     EISSN: 17080428     Source Type: Journal    
DOI: 10.1007/s11695-015-1724-5     Document Type: Article

References (49)

1. Adams TD, Gress RE, Smith SC, et al. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007;357(8):753–61.
2. de la Cruz-Muñoz N, Messiah SE, Arheart KL, et al. Bariatric surgery significantly decreases the prevalence of type 2 diabetes mellitus and pre-diabetes among morbidly obese multiethnic adults: long-term results. J Am Coll Surg. 2011;212(4):505–13.
3. Gurevich-Panigrahi T, Panigrahi S, Wiechec E, et al. Obesity: pathophysiology and clinical management. Curr Med Chem. 2009;16(4):506–21.
4. Iyengar NM, Hudis CA, Dannenberg AJ. Obesity and cancer: local and systemic mechanisms. Annu Rev Med. 2015;66:297–309.
5. Apovian CM. The clinical and economic consequences of obesity. Am J Manag Care. 2013;19(11 Suppl):s219–28.
6. Arterburn DE, Courcoulas AP. Bariatric surgery for obesity and metabolic conditions in adults. BMJ. 2014;349:g3961.
7. Rodríguez-Carmona Y, López-Alavez FJ, González-Garay AG, et al. Bone mineral density after bariatric surgery. A systematic review. Int J Surg. 2014;12(9):976–82.
8. Al-Shoha A, Qiu S, Palnitkar S, et al. Osteomalacia with bone marrow fibrosis due to severe vitamin D deficiency after a gastrointestinal bypass operation for severe obesity. Endocr Pract. 2009;15(6):528–33.
9. Zittel TT, Zeeb B, Maier GW, et al. High prevalence of bone disorders after gastrectomy. Am J Surg. 1997;174(4):431–8.
10. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539–58.
11. Coates PS, Fernstrom JD, Fernstrom MH, et al. Gastric bypass surgery for morbid obesity leads to an increase in bone turnover and a decrease in bone mass. J Clin Endocrinol Metab. 2004;89(3):1061–5.
12. El-Kadre LJ, Rocha PR, de Almeida Tinoco AC, et al. Calcium metabolism in pre- and postmenopausal morbidly obese women at baseline and after laparoscopic Roux-en-Y gastric bypass. Obes Surg. 2004;14(8):1062–6.
13. Goode LR, Brolin RE, Chowdhury HA, et al. Bone and gastric bypass surgery: effects of dietary calcium and vitamin D. Obes Res. 2004;12(1):40–7.
14. Riedt CS, Brolin RE, Sherrell RM, et al. True fractional calcium absorption is decreased after Roux-en-Y gastric bypass surgery. Obesity (Silver Spring). 2006;14(11):1940–8.
15. Fleischer J, Stein EM, Bessler M, et al. The decline in hip bone density after gastric bypass surgery is associated with extent of weight loss. J Clin Endocrinol Metab. 2008;93(10):3735–40.
16. Mahdy T, Atia S, Farid M, et al. Effect of Roux-en Y gastric bypass on bone metabolism in patients with morbid obesity: Mansoura experiences. Obes Surg. 2008;18(12):1526–31.
17. Carrasco F, Ruz M, Rojas P, et al. Changes in bone mineral density, body composition and adiponectin levels in morbidly obese patients after bariatric surgery. Obes Surg. 2009;19(1):41–6.
18. Bruno C, Fulford AD, Potts JR, et al. Serum markers of bone turnover are increased at six and 18 months after Roux-en-Y bariatric surgery: correlation with the reduction in leptin. J Clin Endocrinol Metab. 2010;95(1):159–66.
19. Vilarrasa N, San José P, García I, et al. Evaluation of bone mineral density loss in morbidly obese women after gastric bypass: 3-year follow-up. Obes Surg. 2011;21(4):465–72.
20. Casagrande DS, Repetto G, Mottin CC, et al. Changes in bone mineral density in women following 1-year gastric bypass surgery. Obes Surg. 2012;22(8):1287–92.
21. Bose M, Teixeira J, Olivan B, et al. Weight loss and incretin responsiveness improve glucose control independently after gastric bypass surgery. J Diabetes. 2010;2(1):47–55.
22. Kaulfers AM, Bean JA, Inge TH, et al. Bone loss in adolescents after bariatric surgery. Pediatrics. 2011;127(4):e956–61.
23. Vilarrasa N, Gómez JM, Elio I, et al. Evaluation of bone disease in morbidly obese women after gastric bypass and risk factors implicated in bone loss. Obes Surg. 2009;19(7):860–6.
24. Valderas JP, Velasco S, Solari S, et al. Increase of bone resorption and the parathyroid hormone in postmenopausal women in the long-term after Roux-en-Y gastric bypass. Obes Surg. 2009;19(8):1132–8.
25. Ott MT, Fanti P, Malluche HH, et al. Biochemical evidence of metabolic bone disease in women following Roux-Y gastric bypass for morbid obesity. Obes Surg. 1992;2(4):341–8.
26. Collazo-Clavell ML, Jimenez A, Hodgson SF, et al. Osteomalacia after Roux-en-Y gastric bypass. Endocr Pract. 2004;10(3):195–8.
27. Ricci TA, Chowdhury HA, Heymsfield SB, et al. Calcium supplementation suppresses bone turnover during weight reduction in postmenopausal women. J Bone Miner Res. 1998;13(6):1045–50.
28. Shapses SA, Riedt C. Bone, body weight, and weight reduction: what are the concerns? J Nutr. 2006;136(6):1453–6.
29. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292(14):1724–37.
30. Schneider BE, Mun EC. Surgical management of morbid obesity. Diabetes Care. 2005;28(2):475–80.
31. Blackburn GL. Solutions in weight control: lessons from gastric surgery. Am J Clin Nutr. 2005;82(1 Suppl):248S–52.
32. Oliván B, Teixeira J, Bose M, et al. Effect of weight loss by diet or gastric bypass surgery on peptide YY3-36 levels. Ann Surg. 2009;249(6):948–53.
33. Canales BK, Schafer AL, Shoback DM, et al. Gastric bypass in obese rats causes bone loss, vitamin D deficiency, metabolic acidosis, and elevated peptide YY. Surg Obes Relat Dis. 2014;10(5):878–84.
34. Al-Rasheid N, Gray R, Sufi P, et al. Chronic elevation of systemic glucagon-like peptide-1 following surgical weight loss: association with nausea and vomiting and effects on adipokines. Obes Surg. 2015;25(2):386–91.
35. Yang J, Feng X, Zhong S, et al. Gastric bypass surgery may improve beta cell apoptosis with ghrelin overexpression in patients with BMI ≥ 32.5 kg/m(2.). Obes Surg. 2014;24(4):561–71.
36. Chen J, Pamuklar Z, Spagnoli A, et al. Serum leptin levels are inversely correlated with omental gene expression of adiponectin and markedly decreased after gastric bypass surgery. Surg Endosc. 2012;26(5):1476–80.
37. von Mach MA, Stoeckli R, Bilz S, et al. Changes in bone mineral content after surgical treatment of morbid obesity. Metabolism. 2004;53(7):918–21.
38. Slater GH, Ren CJ, Siegel N, et al. Serum fat-soluble vitamin deficiency and abnormal calcium metabolism after malabsorptive bariatric surgery. J Gastrointest Surg. 2004;8(1):48–55.
39. Bal B, Koch TR, Finelli FC, et al. Managing medical and surgical disorders after divided Roux-en-Y gastric bypass surgery. Nat Rev Gastroenterol Hepatol. 2010;7(6):320–34.
40. Heber D, Greenway FL, Kaplan LM, et al. Endocrine and nutritional management of the post-bariatric surgery patient: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2010;95(11):4823–43.
41. Aarts EO, Janssen IM, Berends FJ. The gastric sleeve: losing weight as fast as micronutrients? Obes Surg. 2011;21(2):207–11.
42. Khandalavala BN, Hibma PP, Fang X. Prevalence and persistence of vitamin D deficiency in biliopancreatic diversion patients: a retrospective study. Obes Surg. 2010;20(7):881–4.
43. World Health Organization Fact sheet: obesity and overweight. Available online: http://www.who.int/mediacentre/factsheets/fs311/en/.
44. Sjöström L, Narbro K, Sjöström CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357(8):741–52.
45. Scibora LM, Ikramuddin S, Buchwald H, et al. Examining the link between bariatric surgery, bone loss, and osteoporosis: a review of bone density studies. Obes Surg. 2012;22(4):654–67.
46. Johnson JM, Maher JW, Samuel I, et al. Effects of gastric bypass procedures on bone mineral density, calcium, parathyroid hormone, and vitamin D. J Gastrointest Surg. 2005;9(8):1106–11.
47. Yu EW, Bouxsein ML, Roy AE, et al. Bone loss after bariatric surgery: discordant results between DXA and QCT bone density. J Bone Miner Res. 2014;29(3):542–50.
48. Stein EM, Carrelli A, Young P, et al. Bariatric surgery results in cortical bone loss. J Clin Endocrinol Metab. 2013;98(2):541–9.
49. Nakamura KM, Haglind EG, Clowes JA, et al. Fracture risk following bariatric surgery: a population-based study. Osteoporos Int. 2014;25(1):151–8.